Entry Point Capital, LLC Neogenomics Inc Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Entry Point Capital, LLC holds 4,428 shares of NEO stock, worth $72,530. This represents 0.09% of its overall portfolio holdings.
Number of Shares
4,428Holding current value
$72,530% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
278Shares Held
127MCall Options Held
581KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$322 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$231 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$144 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$110 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$108 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $2.06B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...